Over 90% say ‘yes’ to Fresenius
Fresenius, the German healthcare group, completed an amendment to its $1.2bn term loan ‘B’ on Friday, cutting its interest rate by 225bp.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
